Drug Warnings / Recalls Federal Drug Administration (FDA) Reporting Information
MedlinePlus, A guide to more than 9,000 prescription and over-the-counter medications provided by the United States Pharmacopeia (USP) in the USP DI® Advice for the Patient®
New Drugs
The FDA maintains a listing of newly approved drug
therapies by year, back to 1995. This listing
is further broken down by clinical category, as follows:
Cardiology
/ Vascular Diseases
Dental / Maxillofacial Surgery
Dermatology / Plastic Surgery
Endocrinology
Gastroenterology
Hematology
Immunology / Infectious Diseases
Musculoskeletal
Nephrology / Urology
Neurology
Obstetrics / Gynecology
Oncology
Opthalmology
Otolaryngology
Pediatrics /
Neonatology
Pharmacology
/ Toxicology
Psychiatry /
Psychology
Pulmonary /
Respiratory Diseases
Rheumatology
Trauma / Emergency
Medicine
For example, here is the listing for Cardiology / Vascular Diseases for 2000:
ACOVA™ (argatroban) Injection; Anticoagulant for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia.; Texas Biotechnology Corporation and SmithKline Beecham; Approved June 2000
Atacand HCT; For the treatment of hypertension; AstraZeneca LP; Approved September 2000
Betapace AF™ Tablet; For treatment of the irregular heartbeats in patients with atrial fibrillation; Berlex Laboratories, Inc.; Approved February 2000
Diltiazem HCL, Extended-Release Capsules; For the reduction of high blood pressure; Biovail Laboratories, Inc.; Approved January 2000
Innohep (tinzaparin sodium) injectable; For the treatment of acute symptomatic deep vein thrombosis; DUPONT PHARMACEUTICALS CO; Approved July 2000
Lescol XL (fluvastatin sodium) tablet, extended release; For the use as an adjunct to diet to reduce elevated total cholesterol; NOVARTIS PHARMACEUTICALS CORP; Approved October 2000
Nitrostat® (nitroglycerin) Tablets; For the acute relief of an attack or acute prophylaxis of angina pectoris due to coronary artery disease.; Parke-Davis Pharmaceuticals, Ltd.; Approved May 2000
